Hims & Hers’ earnings soar while GLP-1 drug crisis deepens—what this means for investors

Pallavi Madhiraju- November 5, 2024 0

Hims & Hers Health Inc. saw its stock surge following a robust quarterly earnings report, which showcased significant growth in revenue and subscriber numbers. Despite ... Read More

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity

Pallavi Madhiraju- March 9, 2024 0

The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk's Wegovy, a milestone in medical advancements aimed at combating ... Read More